Asset Details
Do you wish to reserve the book?
In a rat model of bypass DuraGraft ameliorates endothelial dysfunction of arterial grafts
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
In a rat model of bypass DuraGraft ameliorates endothelial dysfunction of arterial grafts
Do you wish to request the book?
In a rat model of bypass DuraGraft ameliorates endothelial dysfunction of arterial grafts
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
In a rat model of bypass DuraGraft ameliorates endothelial dysfunction of arterial grafts
2024
Overview
Coronary artery bypass surgery can result in endothelial dysfunction due to ischemia/reperfusion (IR) injury. Previous studies have demonstrated that DuraGraft helps maintain endothelial integrity of saphenous vein grafts during ischemic conditions. In this study, we investigated the potential of DuraGraft to mitigate endothelial dysfunction in arterial grafts after IR injury using an aortic transplantation model. Lewis rats (n = 7–9/group) were divided in three groups. Aortic arches from the control group were prepared and rings were immediately placed in organ baths, while the aortic arches of IR and IR + DuraGraft rats were preserved in saline or DuraGraft, respectively, for 1 h before being transplanted heterotopically. After 1 h after reperfusion, the grafts were explanted, rings were prepared, and mounted in organ baths. Our results demonstrated that the maximum endothelium-dependent vasorelaxation to acetylcholine was significantly impaired in the IR group compared to the control group, but DuraGraft improved it (control: 89 ± 2%; IR: 24 ± 1%; IR + DuraGraft: 48 ± 1%,
p
< 0.05). Immunohistochemical analysis revealed decreased intercellular adhesion molecule-1, 4-hydroxy-2-nonenal, caspase-3 and caspase-8 expression, while endothelial cell adhesion molecule-1 immunoreactivity was increased in the IR + DuraGraft grafts compared to the IR-group. DuraGraft mitigates endothelial dysfunction following IR injury in a rat bypass model. Its protective effect may be attributed, at least in part, to its ability to reduce the inflammatory response, oxidative stress, and apoptosis.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ 692/308
/ 692/699
/ Acetylcholine - pharmacology
/ Adhesion
/ Animals
/ Aorta
/ Bypass
/ Cold
/ Coronary Artery Bypass - adverse effects
/ Coronary Artery Bypass - methods
/ Endothelium, Vascular - drug effects
/ Endothelium, Vascular - metabolism
/ Graft
/ Humanities and Social Sciences
/ Intercellular adhesion molecule 1
/ Intercellular Adhesion Molecule-1 - metabolism
/ Ischemia
/ Male
/ Oxidative Stress - drug effects
/ Rats
/ Reperfusion Injury - metabolism
/ Science
